[Effect of L-DOPA on the development of experimental hyperlipidemia and atherosclerosis].
D000818:Animals; D001011:Aorta / Q000032:analysis; D001161:Arteriosclerosis / Q000517:prevention & control*; D002784:Cholesterol / Q000032:analysis; D006168:Guinea Pigs; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents; D007980:Levodopa / Q000627:therapeutic use*; D008099:Liver / Q000032:analysis; D008297:Male; D011817:Rabbits; D051381:Rats; D014280:Triglycerides / Q000032:analysis
D000960:Hypolipidemic Agents; D014280:Triglycerides; D007980:Levodopa; D002784:Cholesterol
Vliianie L-DOPA na razvitie éksperimental'noĭ giperlipidemii i ateroskleroza.